The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of febrile neutropenia (FN) risk factors (RFs) with incident FN in U.S. commercial and Medicare advantage patients receiving intermediate-risk chemotherapy for non-myeloid cancers between 2009 and 2019.
 
Edward C. Li
Employment - Sandoz
Stock and Other Ownership Interests - Novartis
 
Elizabeth J. Bell
Employment - Optum/UnitedHealth Group
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; EMD Serono; Incyte; Novartis; Optum/UnitedHealth Group; Pfizer
 
Kimberley J. Campbell
Employment - Sandoz-Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Lincy S. Lal
Employment - Optum
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); CLovis Oncology (Inst); EMD Serono/Merck (Inst); Exact Sciences (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sandoz (Inst); Vertex (Inst)
 
Jesse Peterson-Brandt
Employment - Optum/UnitedHealth Group
Stock and Other Ownership Interests - United Health Group
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Optum/UnitedHealth Group; Pfizer (Inst); Sandoz (Inst)
 
Gary H. Lyman
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; G1 Therapeutics; Samsung Bioepis; Sandoz-Novartis; Teva
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bayer